{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:00:31Z","timestamp":1790704831133,"version":"4.1.0"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","award":["MR\/S003800\/1"],"award-info":[{"award-number":["MR\/S003800\/1"]}],"id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000643","name":"Daphne Jackson Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000643","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Scotland","id":[{"id":"https:\/\/ror.org\/00saj4962","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The long-term effects of antidepressant use in pregnancy on child neurodevelopment are unclear; meanwhile antidepressant use in pregnancy is increasing. We aimed to clarify associations between prenatal maternal depression and\/or antidepressant exposure and neurodevelopmental outcomes in school-age children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>This population-wide cohort study included 167,447 children born in Wales, UK between 2009 and 2016, followed until 2022 (mean age 5.68 years) using linked primary care, maternity and education records. Exposures were one or more antidepressant prescriptions during pregnancy or up to one month before conception, and\/or maternal depression diagnosis recorded in the two years before delivery. Outcomes were all-cause and cause-specific special educational need (SEN), including autism spectrum disorder (ASD), sensory impairment, communication difficulties, learning difficulties, physical and medical difficulties, and behavioral-emotional-social difficulties, as well as attention deficit hyperactivity disorder (ADHD). Generalized estimating equation models with an interaction term between maternal depression and antidepressant exposure were used to investigate SEN and causes of SEN. Predicted probabilities and marginal effects were derived to quantify absolute risk. Separate models were fitted for individual antidepressant classes and combinations. Cox proportional hazards regression and flexible parametric survival models were used for time to ADHD diagnosis. Covariates included child sex, area-level deprivation quintile, ethnicity, age, maternal age, smoking, parity, multiple birth and epilepsy.<\/jats:p>\n                    <jats:p>In total, 12,630 children (7.6%) were exposed to untreated depression during pregnancy; 7,005 (4.2%) to treated depression; and 5,996 (3.6%) to antidepressant medication without a recorded depression diagnosis. SEN was associated with both maternal depression (adjusted odds ratio (aOR) 1.25 (95% CI [1.20,1.31])) and antidepressant medication exposure (aOR 1.46 (95% CI [1.38,1.56])). Predicted probabilities of all-cause SEN were highest among children exposed to both maternal depression and antidepressants (26.5 per 100 children (95% CI [25.5,27.5])) and lowest among unexposed children (20.0 per 100 (95% CI [19.8,20.2])). Depression alone was associated with an increase to 23.6 per 100 children (95% CI [22.9,24.3]), while antidepressant exposure without depression was associated with an increase to 26.3 per 100 (95% CI [25.3,27.4]). Antidepressant exposure was associated with a 6.3% absolute increase in SEN risk (95% CI [5.2,7.4]) among children of mothers without depression and 2.9% absolute increase (95% CI [1.7,4.1]) among children of mothers with depression. Associations with antidepressant exposure were observed across multiple outcomes including ASD (aOR 1.59 (95% CI [1.31,1.92])) and ADHD (adjusted hazard ratio (aHR) 1.89 (95% CI [1.57,2.27])). No antidepressant class showed a markedly different association with SEN risk, although tricyclic antidepressants (TCAs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) had significant differences in absolute risk of SEN when comparing treated and untreated depression (TCAs 8.8% (95% CI [3.2,14.4]); SNRIs 8.8% (95% CI [2.6,15.0])). Key limitations include potential confounding by indication and depression severity, as women prescribed antidepressants likely represent a more severely depressed group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Offspring of mothers with depression have a higher risk of SEN that cannot be attributed solely to antidepressant exposure. Prenatal exposure to antidepressants may confer a small additional absolute risk, but findings may partly represent confounding by depression severity. Further research is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004658","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:21:12Z","timestamp":1790702472000},"page":"e1004658","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study"],"prefix":"10.1371","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-7221","authenticated-orcid":true,"given":"Saraid","family":"McIlvride","sequence":"first","affiliation":[{"name":"University of Glasgow","place":["Glasgow, United Kingdom"],"department":["School of Health and Wellbeing"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7416-0436","authenticated-orcid":true,"given":"Neha","family":"Rao","sequence":"additional","affiliation":[{"name":"University of Glasgow","place":["Glasgow, United Kingdom"],"department":["School of Health and Wellbeing"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-1807","authenticated-orcid":true,"given":"Sarjit","family":"Singh","sequence":"additional","affiliation":[{"name":"University of Glasgow","place":["Glasgow, United Kingdom"],"department":["School of Medicine, Dentistry and Nursing"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Nelson","sequence":"additional","affiliation":[{"name":"University of Glasgow","place":["Glasgow, United Kingdom"],"department":["School of Medicine, Dentistry and Nursing"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-7035","authenticated-orcid":true,"given":"Jill P.","family":"Pell","sequence":"additional","affiliation":[{"name":"University of Glasgow","place":["Glasgow, United Kingdom"],"department":["School of Health and Wellbeing"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2185-4502","authenticated-orcid":true,"given":"Michael","family":"Fleming","sequence":"additional","affiliation":[{"name":"University of Glasgow","place":["Glasgow, United Kingdom"],"department":["School of Health and Wellbeing"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"5","key":"pmed.1004658.ref001","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00737-016-0629-1","article-title":"A review of longitudinal studies on antenatal and postnatal depression","volume":"19","author":"L Underwood","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"pmed.1004658.ref002","volume-title":"Saving lives, improving mothers\u2019 care core report - lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2019-21","author":"M Knight","year":"2023"},{"key":"pmed.1004658.ref003","volume-title":"Saving lives, improving mothers\u2019 care compiled report - lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2020-22. University of","author":"A Felker","year":"2024"},{"issue":"6","key":"pmed.1004658.ref004","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s10995-014-1637-2","article-title":"Prenatal depression and adverse birth outcomes: an updated systematic review","volume":"19","author":"EE Accortt","year":"2015","journal-title":"Matern Child Health J"},{"key":"pmed.1004658.ref005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroscience.2015.09.001","article-title":"Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review","volume":"342","author":"S Gentile","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"pmed.1004658.ref006","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.12r07968","article-title":"The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis","volume":"74","author":"S Grigoriadis","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"pmed.1004658.ref007","doi-asserted-by":"crossref","first-page":"105243","DOI":"10.1016\/j.earlhumdev.2020.105243","article-title":"Depression during pregnancy and the risk of low birth weight, preterm birth and intrauterine growth restriction- an updated meta-analysis","volume":"152","author":"U Ghimire","year":"2021","journal-title":"Early Hum Dev"},{"issue":"11","key":"pmed.1004658.ref008","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamapediatrics.2020.2910","article-title":"Association between maternal perinatal depression and anxiety and child and adolescent development: a meta-analysis","volume":"174","author":"A Rogers","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"1","key":"pmed.1004658.ref009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/acps.13120","article-title":"In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review","volume":"141","author":"CA Fitton","year":"2020","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"pmed.1004658.ref010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.bp.113.127746","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children","volume":"205","author":"H El Marroun","year":"2014","journal-title":"Br J Psychiatry"},{"issue":"11","key":"pmed.1004658.ref011","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","article-title":"Antidepressant use during pregnancy and childhood autism spectrum disorders","volume":"68","author":"LA Croen","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"15","key":"pmed.1004658.ref012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/AQTF4490","article-title":"Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children","volume":"27","author":"H Heuvelman","year":"2023","journal-title":"Health Technol Assess"},{"issue":"12","key":"pmed.1004658.ref013","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1007\/s00787-024-02460-4","article-title":"Association between maternal antidepressant use during pregnancy and the risk of autism spectrum disorder and attention deficit hyperactivity disorder in offspring","volume":"33","author":"M-J Lee","year":"2024","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"pmed.1004658.ref014","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/mp.2014.90","article-title":"Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system","volume":"20","author":"CC Clements","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"1","key":"pmed.1004658.ref015","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.190","article-title":"Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study","volume":"6","author":"VM Castro","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"5","key":"pmed.1004658.ref016","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaac.2016.02.013","article-title":"Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study","volume":"55","author":"H Malm","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"25","key":"pmed.1004658.ref017","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","article-title":"Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism","volume":"369","author":"A Hviid","year":"2013","journal-title":"N Engl J Med"},{"key":"pmed.1004658.ref018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1472-6963-9-157","article-title":"The SAIL Databank: building a national architecture for e-health research and evaluation","volume":"9","author":"DV Ford","year":"2009","journal-title":"BMC Health Serv Res"},{"issue":"100","key":"pmed.1004658.ref019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jbi.2014.01.003","article-title":"A case study of the Secure Anonymous Information Linkage (SAIL) Gateway: a privacy-protecting remote access system for health-related research and evaluation","volume":"50","author":"KH Jones","year":"2014","journal-title":"J Biomed Inform"},{"key":"pmed.1004658.ref020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6947-9-3","article-title":"The SAIL databank: linking multiple health and social care datasets","volume":"9","author":"RA Lyons","year":"2009","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"pmed.1004658.ref021","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.healthplace.2011.09.006","article-title":"Protecting health data privacy while using residence-based environment and demographic data","volume":"18","author":"SE Rodgers","year":"2012","journal-title":"Health Place"},{"issue":"4","key":"pmed.1004658.ref022","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/pubmed\/fdp041","article-title":"Residential Anonymous Linking Fields (RALFs): a novel information infrastructure to study the interaction between the environment and individuals\u2019 health","volume":"31","author":"SE Rodgers","year":"2009","journal-title":"J Public Health (Oxf)"},{"key":"pmed.1004658.ref023","author":"Welsh Government","year":"2015"},{"key":"pmed.1004658.ref024","year":"2024"},{"issue":"3","key":"pmed.1004658.ref025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003931","article-title":"Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: a comparison of longitudinal cohort studies","volume":"19","author":"P Hanlon","year":"2022","journal-title":"PLoS Med"},{"issue":"11","key":"pmed.1004658.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225133","article-title":"Antidepressant prescriptions, discontinuation, depression and perinatal outcomes, including breastfeeding: a population cohort analysis","volume":"14","author":"S Jordan","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"pmed.1004658.ref027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067882","article-title":"Effects of the COVID-19 pandemic on the mental health of clinically extremely vulnerable children and children living with clinically extremely vulnerable people in Wales: a data linkage study","volume":"13","author":"LE Cowley","year":"2023","journal-title":"BMJ Open"},{"key":"pmed.1004658.ref028","author":"ERD Kontopantelis","year":"2021"},{"issue":"1","key":"pmed.1004658.ref029","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12911-016-0400-6","article-title":"Development of an algorithm for determining smoking status and behaviour over the life course from UK electronic primary care records","volume":"17","author":"MD Atkinson","year":"2017","journal-title":"BMC Med Inform Decis Mak"},{"key":"pmed.1004658.ref030","author":"Welsh Government","year":"2009"},{"key":"pmed.1004658.ref031","volume-title":"QIC: Stata module to compute model selection criterion in GEE analyses","author":"J Cui","year":"2008"},{"key":"pmed.1004658.ref032","author":"P Lambert","year":"2023"},{"key":"pmed.1004658.ref033","article-title":"Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study","volume":"368","author":"KF Huybrechts","year":"2020","journal-title":"BMJ"},{"issue":"3","key":"pmed.1004658.ref034","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/17512433.2023.2181157","article-title":"Safety of drugs used for the treatment of migraine during pregnancy: a narrative review","volume":"16","author":"JA Spiteri","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"pmed.1004658.ref035","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2147\/CLEP.S180618","article-title":"Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring","volume":"10","author":"KW Hagberg","year":"2018","journal-title":"Clin Epidemiol"},{"key":"pmed.1004658.ref036","article-title":"Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study","volume":"346","author":"D Rai","year":"2013","journal-title":"BMJ"},{"key":"pmed.1004658.ref037","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2019.01.038","article-title":"Risk of autistic spectrum disorder in offspring with parental mood disorders: A systematic review and meta-analysis","volume":"248","author":"G Ayano","year":"2019","journal-title":"J Affect Disord"},{"issue":"12","key":"pmed.1004658.ref038","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1038\/s41380-025-03263-y","article-title":"Depression and antidepressant use in pregnancy and adverse maternal and offspring outcomes: a systematic review and meta-analysis","volume":"30","author":"T Liu","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"7","key":"pmed.1004658.ref039","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1007\/s10995-013-1418-3","article-title":"Prenatal and postnatal maternal mental health and school-age child development: a systematic review","volume":"18","author":"D Kingston","year":"2014","journal-title":"Matern Child Health J"},{"issue":"10","key":"pmed.1004658.ref040","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2017.1727","article-title":"Association of antidepressant medication use during pregnancy with intellectual disability in offspring","volume":"74","author":"A Viktorin","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"16","key":"pmed.1004658.ref041","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1017\/S0033291717001301","article-title":"Autism risk following antidepressant medication during pregnancy","volume":"47","author":"A Viktorin","year":"2017","journal-title":"Psychol Med"},{"issue":"15","key":"pmed.1004658.ref042","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2017.3413","article-title":"Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring","volume":"317","author":"AC Sujan","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"pmed.1004658.ref043","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003507","article-title":"In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study","volume":"3","author":"K Laugesen","year":"2013","journal-title":"BMJ Open"},{"key":"pmed.1004658.ref044","first-page":"1","article-title":"Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: a systematic review and meta-analysis","volume":"86","author":"KKC Man","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"pmed.1004658.ref045","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jamainternmed.2022.4268","article-title":"Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children","volume":"182","author":"EA Suarez","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"4","key":"pmed.1004658.ref046","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ppe.12378","article-title":"Antidepressant use in pregnancy and the risk of attention deficit with or without hyperactivity disorder in children","volume":"31","author":"T Boukhris","year":"2017","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"2","key":"pmed.1004658.ref047","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapediatrics.2015.3356","article-title":"Antidepressant use during pregnancy and the risk of autism spectrum disorder in children","volume":"170","author":"T Boukhris","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"8","key":"pmed.1004658.ref048","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","article-title":"Use of antidepressants during pregnancy and risk of attention-deficit\/hyperactivity disorder in the offspring","volume":"31","author":"R Figueroa","year":"2010","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"pmed.1004658.ref049","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12916-018-1193-5","article-title":"Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births","volume":"16","author":"S-Y Gao","year":"2018","journal-title":"BMC Med"},{"key":"pmed.1004658.ref050","article-title":"Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study","volume":"357","author":"KKC Man","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"pmed.1004658.ref051","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1111\/1471-0528.16743","article-title":"Attention-deficit\/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study","volume":"128","author":"A Lupattelli","year":"2021","journal-title":"BJOG"},{"issue":"6","key":"pmed.1004658.ref052","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2215-0366(26)00089-1","article-title":"Maternal and paternal antidepressant use before and during pregnancy and offspring risk of neurodevelopmental disorders: a systematic review and meta-analysis","volume":"13","author":"JKN Chan","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"pmed.1004658.ref053","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S53009","article-title":"Antidepressant exposure in pregnancy and risk of autism spectrum disorders","volume":"5","author":"MJ S\u00f8rensen","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"15","key":"pmed.1004658.ref054","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/jama.2017.3415","article-title":"Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children","volume":"317","author":"HK Brown","year":"2017","journal-title":"JAMA"},{"key":"pmed.1004658.ref055","doi-asserted-by":"crossref","first-page":"1000018","DOI":"10.3389\/fphar.2022.1000018","article-title":"In utero antidepressant exposure not associated with ADHD in the offspring: a case control sibling design","volume":"13","author":"CAM Hartwig","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"pmed.1004658.ref056","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/ije\/dyv030","article-title":"Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings","volume":"44","author":"RE Brandlistuen","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pmed.1004658.ref057","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jcpp.13004","article-title":"Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research","volume":"60","author":"AC Sujan","year":"2019","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"pmed.1004658.ref058","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/EDE.0b013e31825fa230","article-title":"Sibling comparison designs: bias from non-shared confounders and measurement error","volume":"23","author":"T Frisell","year":"2012","journal-title":"Epidemiology"},{"issue":"6","key":"pmed.1004658.ref059","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41390-020-01269-6","article-title":"Prenatal antidepressant exposure and child development at kindergarten age: a population-based study","volume":"89","author":"M Park","year":"2021","journal-title":"Pediatr Res"},{"key":"pmed.1004658.ref060","author":"National Institute for Health and Care Excellence","year":"2023"},{"issue":"11","key":"pmed.1004658.ref061","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study","volume":"159","author":"I Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"3","key":"pmed.1004658.ref062","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaac.2017.12.010","article-title":"Effect of time-dependent selective serotonin reuptake inhibitor antidepressants during pregnancy on behavioral, emotional, and social development in preschool-aged children","volume":"57","author":"A Lupattelli","year":"2018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"pmed.1004658.ref063","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13034-023-00624-9","article-title":"Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study","volume":"17","author":"M Bliddal","year":"2023","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"pmed.1004658.ref064","author":"C Knight","year":"2024"},{"issue":"1","key":"pmed.1004658.ref065","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.15r10194","article-title":"The association between antenatal exposure to selective serotonin reuptake inhibitors and autism: a systematic review and meta-analysis","volume":"78","author":"HK Brown","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"pmed.1004658.ref066","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12916-017-0993-3","article-title":"Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations","volume":"16","author":"DR Morales","year":"2018","journal-title":"BMC Med"},{"issue":"6","key":"pmed.1004658.ref067","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1176\/appi.ajp.2020.18070766","article-title":"Implementation of advanced methods for reproductive pharmacovigilance in autism: a meta-analysis of the effects of prenatal antidepressant exposure","volume":"177","author":"ML Vega","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"1","key":"pmed.1004658.ref068","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41398-023-02441-2","article-title":"Effects of prenatal exposure to (es)citalopram and maternal depression during pregnancy on DNA methylation and child neurodevelopment","volume":"13","author":"EW Olstad","year":"2023","journal-title":"Transl Psychiatry"},{"issue":"4","key":"pmed.1004658.ref069","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10995-014-1591-z","article-title":"New evidence on breastfeeding and postpartum depression: the importance of understanding women\u2019s intentions","volume":"19","author":"C Borra","year":"2015","journal-title":"Matern Child Health J"},{"key":"pmed.1004658.ref070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jad.2022.04.091","article-title":"Association between breastfeeding and postpartum depression: a meta-analysis","volume":"308","author":"M Xia","year":"2022","journal-title":"J Affect Disord"},{"issue":"5","key":"pmed.1004658.ref071","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1469-7610.2007.01857.x","article-title":"Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample","volume":"49","author":"A Ronald","year":"2008","journal-title":"J Child Psychol Psychiatry"},{"issue":"4","key":"pmed.1004658.ref072","article-title":"Attention-deficit hyperactivity disorder diagnoses and prescriptions in UK primary care, 2000-2018: population-based cohort study","volume":"9","author":"DGJ McKechnie","year":"2023","journal-title":"BJPsych Open"},{"key":"pmed.1004658.ref073","doi-asserted-by":"crossref","first-page":"100626","DOI":"10.1016\/j.lanepe.2023.100626","article-title":"Autism in England: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care data","volume":"29","author":"E O\u2019Nions","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"36","key":"pmed.1004658.ref074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/TDAS1298","article-title":"Accessibility and acceptability of perinatal mental health services for women from ethnic minority groups: a synopsis of the PAAM study","volume":"13","author":"N Jovanovi\u0107","year":"2025","journal-title":"Health Soc Care Deliv Res"},{"issue":"11","key":"pmed.1004658.ref075","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20958","article-title":"Psychiatric illness and pregnancy: a literature review","volume":"9","author":"MA Abdelhafez","year":"2023","journal-title":"Heliyon"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:21:25Z","timestamp":1790702485000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004658"}},"subtitle":[],"editor":[{"given":"Lars \u00c5ke","family":"Persson","sequence":"first","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":75,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004658","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}